Categories: News

Hifinite Showcased Its hiCare Suite of Digital Healthcare Products at ATA 2019

SAN DIEGO, April 17, 2019 /PRNewswire/ — Hifinite announced its newest release of hiCare products at the ATA Annual Conference and Expo 2019 in New Orleans, LA. Attendees got a glimpse of Hifinite’s innovative solutions for chronic disease management, medication adherence, and on-demand telemedicine services.

The hiCare suite is a cloud-based, HIPAA-compliant digital healthcare platform available to access on web browsers, iOS and Android mobile devices, Google and Amazon digital assistants, smart TVs, and smartwatches. hiCare has connectivity to a multitude of medical sensors, integrations with multiple EHRs/EMRs, pharmacies, labs, insurance, and billing systems. It also includes sophisticated health analytics with a rules-based workflow and reporting engine. Medical sensor connectivity includes BP monitors, spirometers, glucometers, pulse oximeters, weight scales, thermometers, pill dispenser, and activity trackers. Hifinite empowers partners with private labeling and allows for delivery in a Module as a Service (MaaS) model to optimally utilize the services and pay for what is used. Hifinite’s solutions provide the best value for the lowest cost in the industry.

hiCare Chronic Disease Management allows providers to manage chronic diseases for patients. It also allows friends and family members to actively participate in managing the patient’s health. Features include real-time remote patient monitoring coupled with caregiver participation, care plans, custom dashboards for all parties involved, and tele-consult abilities. Insightful analytics and streamlined workflows make user engagement optimum. Post-hospitalization care modules help keep the hospital readmission rates low for chronic patients.

hiCare Comply, a medication adherence platform, helps improve medication adherence, resulting in improved health outcomes and significant cost savings for payers. The solution is offered with an integrated smart pillbox, real-time monitoring and tracking, custom medication scheduling, along with back-end technologies to facilitate pharmacists and nurses to be on-call, thereby assisting patients to improve outcomes and reduce costs for providers.

hiCare Consult allows providers to give telemedicine services to their patients at will, thereby facilitating convenience and improving outcomes. The features include an easy activation process, access to specialists, pharmacy integration, custom workflows, medical history management, real-time tracking, and actionable analytics. Providers benefit from centralized operations and real-time back office management.

Hifinite’s Chief Commercial Officer, Matt Weisensee, said, “There is an opportunity for providers to mitigate risk, reduce hospital readmission rates, reduce healthcare spending, improve care outcomes, and reduce costs. Implementing and streamlining new technologies helps all parties. In a traditional healthcare setting, almost all data and insights of a patient’s health are lost the moment the patient leaves the clinic or hospital.”

About Hifinite

Hifinite is a digital healthcare solutions provider that offers several innovative solutions to engage, consult, educate, and remotely monitor patients. Designed with integration at its core, Hifinite delivers leading-edge healthcare technology of the future, today. Available on common modalities, Hifinite offers an innovative solution called hiCare, delivered in a Module as a Service (MaaS) model helps patients lead a happy and healthy life, while helping payers mitigate risk, thereby saving time, money, and lives. http://www.hifinite.com. For more information, please contact hifi.info@hifinite.com.

Related Images

image1.png

View original content to download multimedia:http://www.prnewswire.com/news-releases/hifinite-showcased-its-hicare-suite-of-digital-healthcare-products-at-ata-2019-300833937.html

SOURCE Hifinite

Staff

Recent Posts

ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN…

2 days ago

LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders

BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB)…

2 days ago

Lowell Farms Inc. Announces Change of Chief Financial Officer

SALINAS, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL;…

2 days ago

PetVivo Reports Reports Fiscal 2024 Results

MINNEAPOLIS, MN, US, June 28, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW),…

2 days ago

Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024

BETHESDA, Md., June 28, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or…

2 days ago

Cellectis Reports Results from Shareholders Meeting Held on June 28, 2024

NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a…

2 days ago